{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:44:04Z","timestamp":1792097044738,"version":"4.4.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"DOI":"10.1186\/s10194-025-02027-x","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T10:57:23Z","timestamp":1744628243000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Differences in pharmacological migraine treatment across different levels of clinical headache care \u2013 a cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"given":"Mira Pauline","family":"Fitzek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Hendrik","family":"Overeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ja Bin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin Luisa","family":"Hoehne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin Sophie","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yones","family":"Salim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Reuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Raffaelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"key":"2027_CR1","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"GBD","year":"2021","unstructured":"GBD (2021) Nervous System Disorders Collaborators (2024) Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol 23:344\u2013381. https:\/\/doi.org\/10.1016\/S1474-4422(24)00038-3","journal-title":"Lancet Neurol"},{"key":"2027_CR2","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1177\/0333102411398400","volume":"31","author":"M Lant\u00e9ri-Minet","year":"2011","unstructured":"Lant\u00e9ri-Minet M, Duru G, Mudge M, Cottrell S (2011) Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: a systematic review. Cephalalgia 31:837\u2013850. https:\/\/doi.org\/10.1177\/0333102411398400","journal-title":"Cephalalgia"},{"key":"2027_CR3","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1080\/13696998.2021.1925557","volume":"24","author":"P Martelletti","year":"2021","unstructured":"Martelletti P, Schwedt TJ, Vo P et al (2021) Healthcare resource use and indirect costs associated with migraine in Italy: results from the My Migraine Voice survey. J Med Econ 24:717\u2013726. https:\/\/doi.org\/10.1080\/13696998.2021.1925557","journal-title":"J Med Econ"},{"key":"2027_CR4","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1111\/head.13613","volume":"59","author":"DC Buse","year":"2019","unstructured":"Buse DC, Fanning KM, Reed ML et al (2019) Life With Migraine: Effects on Relationships, Career, and Finances From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Headache 59:1286\u20131299. https:\/\/doi.org\/10.1111\/head.13613","journal-title":"Headache"},{"key":"2027_CR5","doi-asserted-by":"publisher","first-page":"e0208728","DOI":"10.1371\/journal.pone.0208728","volume":"14","author":"J Munoz-Ceron","year":"2019","unstructured":"Munoz-Ceron J, Marin-Careaga V, Pe\u00f1a L et al (2019) Headache at the emergency room: Etiologies, diagnostic usefulness of the ICHD 3 criteria, red and green flags. PLoS ONE 14:e0208728. https:\/\/doi.org\/10.1371\/journal.pone.0208728","journal-title":"PLoS ONE"},{"key":"2027_CR6","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/j.1468-1331.2011.03612.x","volume":"19","author":"M Linde","year":"2012","unstructured":"Linde M, Gustavsson A, Stovner LJ et al (2012) The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol 19:703\u2013711. https:\/\/doi.org\/10.1111\/j.1468-1331.2011.03612.x","journal-title":"Eur J Neurol"},{"key":"2027_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s10194-024-01740-3","volume":"25","author":"D Garc\u00eda-Azor\u00edn","year":"2024","unstructured":"Garc\u00eda-Azor\u00edn D, Moya-Alarc\u00f3n C, Armada B, S\u00e1nchez del R\u00edo M (2024) Societal and economic burden of migraine in Spain: results from the 2020 National Health and Wellness Survey. J Headache Pain 25:38. https:\/\/doi.org\/10.1186\/s10194-024-01740-3","journal-title":"J Headache Pain"},{"key":"2027_CR8","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0140-6736(20)32160-7","volume":"397","author":"M Ashina","year":"2021","unstructured":"Ashina M, Katsarava Z, Do TP et al (2021) Migraine: epidemiology and systems of care. The Lancet 397:1485\u20131495. https:\/\/doi.org\/10.1016\/S0140-6736(20)32160-7","journal-title":"The Lancet"},{"key":"2027_CR9","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.mayocp.2016.02.013","volume":"91","author":"DC Buse","year":"2016","unstructured":"Buse DC, Scher AI, Dodick DW et al (2016) Impact of Migraine on the Family: Perspectives of People With Migraine and Their Spouse\/Domestic Partner in the CaMEO Study. Mayo Clin Proc 91:596\u2013611. https:\/\/doi.org\/10.1016\/j.mayocp.2016.02.013","journal-title":"Mayo Clin Proc"},{"key":"2027_CR10","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/head.14289","volume":"62","author":"L Harris","year":"2022","unstructured":"Harris L, L\u2019Italien G, Kumar A et al (2022) Real-world assessment of the relationship between migraine-related disability and healthcare costs in the United States. Headache 62:473\u2013481. https:\/\/doi.org\/10.1111\/head.14289","journal-title":"Headache"},{"key":"2027_CR11","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1080\/13696998.2021.1953301","volume":"24","author":"P Vo","year":"2021","unstructured":"Vo P, Swallow E, Wu E et al (2021) Real-world migraine-related healthcare resource utilization and costs associated with improved vs. worsened\/stable migraine: a panel-based chart review in France, Germany, Italy, and Spain. J Med Econ 24:900\u2013907. https:\/\/doi.org\/10.1080\/13696998.2021.1953301","journal-title":"J Med Econ"},{"key":"2027_CR12","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s10194-024-01882-4","volume":"25","author":"ACT Tam","year":"2024","unstructured":"Tam ACT, Naik H, Trenaman L et al (2024) Health-related quality of life among women and men living with migraine: a Canada-wide cross-sectional study. J Headache Pain 25:170. https:\/\/doi.org\/10.1186\/s10194-024-01882-4","journal-title":"J Headache Pain"},{"key":"2027_CR13","doi-asserted-by":"publisher","first-page":"333102424125266","DOI":"10.1177\/03331024241252666","volume":"44","author":"F Puledda","year":"2024","unstructured":"Puledda F, Sacco S, Diener H-C et al (2024) International Headache Society global practice recommendations for the acute pharmacological treatment of migraine. Cephalalgia 44:3331024241252666. https:\/\/doi.org\/10.1177\/03331024241252666","journal-title":"Cephalalgia"},{"key":"2027_CR14","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-021-00509-5","volume":"17","author":"AK Eigenbrodt","year":"2021","unstructured":"Eigenbrodt AK, Ashina H, Khan S et al (2021) Diagnosis and management of migraine in ten steps. Nat Rev Neurol 17:501\u2013514. https:\/\/doi.org\/10.1038\/s41582-021-00509-5","journal-title":"Nat Rev Neurol"},{"key":"2027_CR15","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1055\/s-0038-1673598","volume":"37","author":"H-C Diener","year":"2018","unstructured":"Diener H-C, Gaul C, Kropp P (2018) Therapie der Migr\u00e4neattacke und Prophylaxe der Migr\u00e4ne: Entwicklungsstufe: S1. Nervenheilkunde 37:689\u2013715. https:\/\/doi.org\/10.1055\/s-0038-1673598","journal-title":"Nervenheilkunde"},{"key":"2027_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s10194-022-01431-x","volume":"23","author":"S Sacco","year":"2022","unstructured":"Sacco S, Amin FM, Ashina M et al (2022) European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 update. J Headache Pain 23:67. https:\/\/doi.org\/10.1186\/s10194-022-01431-x","journal-title":"J Headache Pain"},{"key":"2027_CR17","unstructured":"Gemeinsamer Bundesausschuss. Erstattungsbetragsverhandlungen nach \u00a7 130b SGB V. https:\/\/www.gkv-spitzenverband.de\/krankenversicherung\/arzneimittel\/verhandlungen_nach_amnog\/ebv_130b\/wirkstoff_954688.jsp. Accessed 4 Apr 2025"},{"key":"2027_CR18","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s10194-023-01682-2","volume":"24","author":"JB Hong","year":"2023","unstructured":"Hong JB, Lange KS, Fitzek M et al (2023) Impact of a reimbursement policy change on treatment with erenumab in migraine - a real-world experience from Germany. J Headache Pain 24:144. https:\/\/doi.org\/10.1186\/s10194-023-01682-2","journal-title":"J Headache Pain"},{"key":"2027_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s10194-024-01832-0","volume":"25","author":"Z Chen","year":"2024","unstructured":"Chen Z, Kong X, Yang C et al (2024) Global, regional, and national burden and trends of migraine among youths and young adults aged 15\u201339 years from 1990 to 2021: findings from the global burden of disease study 2021. J Headache Pain 25:131. https:\/\/doi.org\/10.1186\/s10194-024-01832-0","journal-title":"J Headache Pain"},{"key":"2027_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10194-011-0320-x","volume":"12","author":"TJ Steiner","year":"2011","unstructured":"Steiner TJ, Antonaci F, Jensen R et al (2011) Recommendations for headache service organisation and delivery in Europe. J Headache Pain 12:419\u2013426. https:\/\/doi.org\/10.1007\/s10194-011-0320-x","journal-title":"J Headache Pain"},{"key":"2027_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12883-024-03600-8","volume":"24","author":"P Pozo-Rosich","year":"2024","unstructured":"Pozo-Rosich P, Carmo M, Mu\u00f1iz A et al (2024) Migraine treatment: quo vadis? Real-world data study (2015\u20132022) in Spain. BMC Neurol 24:107. https:\/\/doi.org\/10.1186\/s12883-024-03600-8","journal-title":"BMC Neurol"},{"key":"2027_CR22","unstructured":"World Health Organization (2011) Atlas of headache disorders and resources in the world 2011. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241564212. Accessed 31 Dec 2024"},{"key":"2027_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s10194-024-01937-6","volume":"26","author":"LH Overeem","year":"2025","unstructured":"Overeem LH, Ulrich M, Fitzek MP et al (2025) Consistency between headache diagnoses and ICHD-3 criteria across different levels of care. J Headache Pain 26:6. https:\/\/doi.org\/10.1186\/s10194-024-01937-6","journal-title":"J Headache Pain"},{"key":"2027_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s10194-023-01699-7","volume":"24","author":"B Raffaelli","year":"2023","unstructured":"Raffaelli B, Rubio-Beltr\u00e1n E, Cho S-J et al (2023) Health equity, care access and quality in headache \u2013 part 2. J Headache Pain 24:167. https:\/\/doi.org\/10.1186\/s10194-023-01699-7","journal-title":"J Headache Pain"},{"key":"2027_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s10194-018-0899-2","volume":"20","author":"TJ Steiner","year":"2019","unstructured":"Steiner TJ, Jensen R, Katsarava Z et al (2019) Aids to management of headache disorders in primary care (2nd edition): on behalf of the European Headache Federation and Lifting The Burden: the Global Campaign against Headache. J Headache Pain 20:57. https:\/\/doi.org\/10.1186\/s10194-018-0899-2","journal-title":"J Headache Pain"},{"key":"2027_CR26","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/head.12803","volume":"56","author":"M Minen","year":"2016","unstructured":"Minen M, Shome A, Halpern A et al (2016) A migraine management training program for primary care providers: An overview of a survey and pilot study findings, lessons learned, and considerations for further research. Headache 56:725\u2013740. https:\/\/doi.org\/10.1111\/head.12803","journal-title":"Headache"},{"key":"2027_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s10194-024-01889-x","volume":"25","author":"A Raggi","year":"2024","unstructured":"Raggi A, Leonardi M, Arruda M et al (2024) Hallmarks of primary headache: part 1 - migraine. J Headache Pain 25:189. https:\/\/doi.org\/10.1186\/s10194-024-01889-x","journal-title":"J Headache Pain"},{"key":"2027_CR28","doi-asserted-by":"publisher","unstructured":"International Headache Society (2018) Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38:1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202","DOI":"10.1177\/0333102417738202"},{"key":"2027_CR29","doi-asserted-by":"publisher","unstructured":"Katsarava Z, Mania M, Lampl C, et al (2018) Poor medical care for people with migraine in Europe - evidence from the Eurolight study. J Headache Pain 19:10. https:\/\/doi.org\/10.1186\/s10194-018-0839-1","DOI":"10.1186\/s10194-018-0839-1"},{"key":"2027_CR30","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10194-012-0425-x","volume":"13","author":"M-S Yoon","year":"2012","unstructured":"Yoon M-S, Katsarava Z, Obermann M et al (2012) Prevalence of primary headaches in Germany: results of the German Headache Consortium Study. J Headache Pain 13:215\u2013223. https:\/\/doi.org\/10.1007\/s10194-012-0425-x","journal-title":"J Headache Pain"},{"key":"2027_CR31","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/fampra\/cmac121","volume":"41","author":"LN Carlsen","year":"2024","unstructured":"Carlsen LN, Stefansen S, Ahnfeldt-Mollerup P et al (2024) Diagnostics and management of headache in general practice. Fam Pract 41:470\u2013476. https:\/\/doi.org\/10.1093\/fampra\/cmac121","journal-title":"Fam Pract"},{"key":"2027_CR32","doi-asserted-by":"publisher","first-page":"e335","DOI":"10.1016\/S2468-2667(22)00013-5","volume":"7","author":"C Ju","year":"2022","unstructured":"Ju C, Wei L, Man KKC et al (2022) Global, regional, and national trends in opioid analgesic consumption from 2015 to 2019: a longitudinal study. Lancet Public Health 7:e335\u2013e346. https:\/\/doi.org\/10.1016\/S2468-2667(22)00013-5","journal-title":"Lancet Public Health"},{"key":"2027_CR33","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/ene.14268","volume":"27","author":"HC Diener","year":"2020","unstructured":"Diener HC, Antonaci F, Braschinsky M et al (2020) European Academy of Neurology guideline on the management of medication-overuse headache. Eur J Neurol 27:1102\u20131116. https:\/\/doi.org\/10.1111\/ene.14268","journal-title":"Eur J Neurol"},{"key":"2027_CR34","doi-asserted-by":"publisher","first-page":"8487","DOI":"10.1038\/s41598-022-12545-2","volume":"12","author":"A Olesen","year":"2022","unstructured":"Olesen A, Schytz HW, Ostrowski SR et al (2022) Low adherence to the guideline for the acute treatment of migraine. Sci Rep 12:8487. https:\/\/doi.org\/10.1038\/s41598-022-12545-2","journal-title":"Sci Rep"},{"key":"2027_CR35","doi-asserted-by":"publisher","first-page":"4765","DOI":"10.1007\/s12325-020-01494-9","volume":"37","author":"E Leroux","year":"2020","unstructured":"Leroux E, Buchanan A, Lombard L et al (2020) Evaluation of Patients with Insufficient Efficacy and\/or Tolerability to Triptans for the Acute Treatment of Migraine: A Systematic Literature Review. Adv Ther 37:4765\u20134796. https:\/\/doi.org\/10.1007\/s12325-020-01494-9","journal-title":"Adv Ther"},{"key":"2027_CR36","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s10194-022-01502-z","volume":"23","author":"S Sacco","year":"2022","unstructured":"Sacco S, Lampl C, Amin FM et al (2022) European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure. J Headache Pain 23:133. https:\/\/doi.org\/10.1186\/s10194-022-01502-z","journal-title":"J Headache Pain"},{"key":"2027_CR37","doi-asserted-by":"publisher","first-page":"2514183X1882337","DOI":"10.1177\/2514183X18823377","volume":"3","author":"HC Diener","year":"2019","unstructured":"Diener HC, Holle-Lee D, N\u00e4gel S et al (2019) Treatment of migraine attacks and prevention of migraine: Guidelines by the German Migraine and Headache Society and the German Society of Neurology. Clin Transl Neurosci. 3:2514183X1882337. https:\/\/doi.org\/10.1177\/2514183X18823377","journal-title":"Clin Transl Neurosci."},{"key":"2027_CR38","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1212\/CON.0000000000000199","volume":"21","author":"SD Silberstein","year":"2015","unstructured":"Silberstein SD (2015) Preventive Migraine Treatment. Continuum (Minneap Minn) 21:973\u2013989. https:\/\/doi.org\/10.1212\/CON.0000000000000199","journal-title":"Continuum (Minneap Minn)"},{"key":"2027_CR39","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/head.14153","volume":"61","author":"J Ailani","year":"2021","unstructured":"Ailani J, Burch RC, Robbins MS, Society the B of D of the AH (2021) The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice. Headache. 61:1021\u20131039. https:\/\/doi.org\/10.1111\/head.14153","journal-title":"Headache."},{"key":"2027_CR40","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s10194-023-01686-y","volume":"24","author":"H Mistry","year":"2023","unstructured":"Mistry H, Naghdi S, Underwood M et al (2023) Competing treatments for migraine: a headache for decision-makers. J Headache Pain 24:162. https:\/\/doi.org\/10.1186\/s10194-023-01686-y","journal-title":"J Headache Pain"},{"key":"2027_CR41","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2165\/11314380-000000000-00000","volume":"23","author":"MJA L\u00e1inez","year":"2009","unstructured":"L\u00e1inez MJA (2009) The effect of migraine prophylaxis on migraine-related resource use and productivity. CNS Drugs 23:727\u2013738. https:\/\/doi.org\/10.2165\/11314380-000000000-00000","journal-title":"CNS Drugs"},{"key":"2027_CR42","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s40120-020-00205-4","volume":"9","author":"S Wongsiriroj","year":"2020","unstructured":"Wongsiriroj S, Grillo E, Levi S et al (2020) Management of Migraine and the Accessibility of Specialist Care: Findings from an Extended Multinational Survey (My Migraine Center Survey). Neurol Ther 9:551\u2013565. https:\/\/doi.org\/10.1007\/s40120-020-00205-4","journal-title":"Neurol Ther"},{"key":"2027_CR43","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1177\/0333102410364676","volume":"30","author":"SK Aurora","year":"2010","unstructured":"Aurora SK, Dodick DW, Turkel CC et al (2010) OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia 30:793\u2013803. https:\/\/doi.org\/10.1177\/0333102410364676","journal-title":"Cephalalgia"},{"key":"2027_CR44","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/head.13849","volume":"60","author":"R Burstein","year":"2020","unstructured":"Burstein R, Blumenfeld AM, Silberstein SD et al (2020) Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review. Headache 60:1259\u20131272. https:\/\/doi.org\/10.1111\/head.13849","journal-title":"Headache"},{"key":"2027_CR45","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/S0140-6736(19)32504-8","volume":"394","author":"A Charles","year":"2019","unstructured":"Charles A, Pozo-Rosich P (2019) Targeting calcitonin gene-related peptide: a new era in migraine therapy. Lancet 394:1765\u20131774. https:\/\/doi.org\/10.1016\/S0140-6736(19)32504-8","journal-title":"Lancet"},{"key":"2027_CR46","unstructured":"Gemeinsamer Bundesausschuss. Arzneimittel-Richtlinie\/Anlage IV: Einleitung eines Stellungnahmeverfahrens \u2013 Therapiehinweis zu Botulinumtoxin A und B - Gemeinsamer Bundesausschuss. https:\/\/www.g-ba.de\/beschluesse\/3568\/. Accessed 31 Dec 2024"},{"key":"2027_CR47","doi-asserted-by":"publisher","first-page":"e017902","DOI":"10.1136\/bmjopen-2017-017902","volume":"7","author":"G Irving","year":"2017","unstructured":"Irving G, Neves AL, Dambha-Miller H et al (2017) International variations in primary care physician consultation time: a systematic review of 67 countries. BMJ Open 7:e017902. https:\/\/doi.org\/10.1136\/bmjopen-2017-017902","journal-title":"BMJ Open"},{"key":"2027_CR48","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M et al (2007) Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335:806\u2013808. https:\/\/doi.org\/10.1136\/bmj.39335.541782.AD","journal-title":"BMJ"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-025-02027-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-025-02027-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-025-02027-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T10:57:25Z","timestamp":1744628245000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-025-02027-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2027"],"URL":"https:\/\/doi.org\/10.1186\/s10194-025-02027-x","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin (EA4\/246\/23). Data were kept confidential and were not disclosed unless for study purposes. This study is reported in accordance with the \u201cStrengthening the Reporting of Observational Studies in Epidemiology\u201d (STROBE) statement for cohort studies [48].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"As this was a retrospective analysis, written consent from the participating patients was not required according to local regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MF reports personal fees from Novartis and Teva. KSL reports personal fees from Organon and Teva. UR reports no personal fees; institutional fees from Amgen, Abbvie, Lilly, Lundbeck, Novartis, Medscape, Pfizer, StreaMedUp, and Teva, and research funding from Novartis. UR is the vice-president of the EHF and associate editor of JHP.  BR reports research grants from Lundbeck, Novartis, German Research Foundation, German Migraine and Headache Society, Else Kr\u00f6ne-Fresenius-Stiftung and personal fees from Abbvie\/Allergan, Eli Lilly, Lundbeck, Novartis, Organon, Perfood and Teva. BR is an Editorial Board Member of The Journal of Headache and Pain. LHO, MU, JBH, CLH and YS have nothing to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}